Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/04/2001 | US6326142 Measuring binding of polynucleotide to protein; label nucleotide sequences, measure polarization of fluorescent emission, incubate nucleotide sequence with protein, measure polarization and compare, detect complex formation |
12/04/2001 | US6326141 Detecting pancreatic defect; evaluate humans for preferential gene expression, compare to healty human, amplified expression from preferential gene indicates pancreatic defect |
12/04/2001 | US6326008 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
12/04/2001 | US6326007 Genes responsible for pathogenesis completely or partially nonfunctional by modifying or deleting nef (negative effector) start codon; enhanced expression of cytokine and/or lymphokine; vaccines |
12/04/2001 | US6326001 Recombinant vaccine for diseases caused by encapsulated organisms |
12/04/2001 | US6325999 Use of Fas ligand to suppress T-lymphocyte-mediated immune responses |
12/04/2001 | US6325998 Methods of treating disease using recombinant adeno-associated virus virions administered to muscle |
12/04/2001 | CA2238668C Novel enzyme catalyzing dephosphorylation |
12/04/2001 | CA2218452C Novel ligands of the neuropeptide receptor hfgan72 |
12/04/2001 | CA2203295C High efficiency method for isolating target substances using a multisample separation device |
12/04/2001 | CA2189682C Process for producing trans-4-hydroxy-l-proline |
12/04/2001 | CA2139948C Targeting somatic gene therapy to joints |
12/04/2001 | CA2117581C Protocadherin, their antibodies and uses |
12/04/2001 | CA2110703C Process and culture medium for the production of cells infected by a multiple sclerosis associated virus |
12/04/2001 | CA2087270C Modified baculovirus, method for obtaining it, and expression vectors obtained from said baculovirus |
12/04/2001 | CA2064906C Quantitation of nucleic acids using the polymerase chain reaction |
12/04/2001 | CA2027635C Erythropoietin isoforms |
12/04/2001 | CA2024253C Entities for cancer therapy |
12/04/2001 | CA1341324C Esterase enzymes used in the process for the preparation of 2-arylpropionic acids |
12/01/2001 | CA2347276A1 I g e-dependent histamine-releasing factor (hrf) receptor, hrf-binding peptides and nucleic acids encoding the same, and uses thereof |
11/30/2001 | CA2347249A1 Mutant plk protein and gene encoding the same |
11/29/2001 | WO2001090750A1 Method for examining wt1-related disease |
11/29/2001 | WO2001090421A2 Method of detecting inflammatory lung disorders |
11/29/2001 | WO2001090420A1 Drug-oligonucleotides chimeric molecules |
11/29/2001 | WO2001090419A2 Methods for genetic analysis of dna to detect sequence variances |
11/29/2001 | WO2001090417A2 Materials and methods for detection of nucleic acids |
11/29/2001 | WO2001090415A2 Method of producing a dna library using positional amplification |
11/29/2001 | WO2001090414A1 In vitro evolution of nucleic acids and encoded polypeptide |
11/29/2001 | WO2001090408A2 Method for detecting and characterising activity of proteins involved in lesion and dna repair |
11/29/2001 | WO2001090404A1 Drug screening systems and assays |
11/29/2001 | WO2001090393A1 Method for increasing gene copy number in a host cell and resulting host cell |
11/29/2001 | WO2001090392A1 Novel recombinant adenovirus vector with relieved side effects |
11/29/2001 | WO2001090391A2 Utilization of non-viral sequences for minus-strand dna transfer and gene reconstitution |
11/29/2001 | WO2001090390A1 Use of baculovirus vectors in gene therapy |
11/29/2001 | WO2001090389A2 Production of silk-like proteins in plants |
11/29/2001 | WO2001090388A1 Gene controlling shoot branching in plants |
11/29/2001 | WO2001090387A2 Gene regulatory region that promotes root-specific transcription and its uses |
11/29/2001 | WO2001090386A2 Gene regulatory region that promotes early seed-specific transcription |
11/29/2001 | WO2001090385A2 IRON REGULATION OF THE PpSEC10 TRANSCRIPTIONAL REGULATORY REGION OF PICHIA PASTORIS AND METHODS OF USE |
11/29/2001 | WO2001090384A1 Viral vectors useful in induction of humoral or cellular immunity |
11/29/2001 | WO2001090383A2 Co-expression of recombinant proteins |
11/29/2001 | WO2001090381A1 Novel polypeptide - a human alpha interferon receptor 115.62 and polynucleotide encoding it |
11/29/2001 | WO2001090380A1 Novel polypeptide - a human turnover gene-2-beta protein 11.99 and polynucleotide encoding it |
11/29/2001 | WO2001090379A1 Novel polypeptide - a human basophil granule protein 22.55 and polynucleotide encoding it |
11/29/2001 | WO2001090378A1 Novel polypeptide--- a human hexokinase protein and polynucleotide encoding it |
11/29/2001 | WO2001090377A1 Novel polypeptide - a human von hippel lindau tumour suppressor gene 14 and polynucleotide encoding it |
11/29/2001 | WO2001090376A1 Novel polypeptide - a human triose phosphate isomerase 11 and polynucleotide encoding it |
11/29/2001 | WO2001090375A1 Endoglucanase nce5 and cellulase preparations containing the same |
11/29/2001 | WO2001090374A2 26493, a human mutt dgtpase family member and uses thereof |
11/29/2001 | WO2001090373A1 A novel polypeptide, a human protein phosphatase 4 regulatory subunit 37 and the polynucleotide encoding the polypeptide |
11/29/2001 | WO2001090372A1 Lactobacillus reuteri glucosyltransferase |
11/29/2001 | WO2001090371A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome) |
11/29/2001 | WO2001090370A2 Method for microbial production of difructose anhydride iii, micro-organism used therefor and enzyme with inulase ii activity and dna sequences coding therefor |
11/29/2001 | WO2001090369A1 A novel polypeptide, a human n-acetylgalactosamine transferase -28 and the polynucleotide encoding the polypeptide |
11/29/2001 | WO2001090368A1 A novel polypeptide, a human protein 9 containing glutamine transferase active site and the polynucleotide encoding the polypeptide |
11/29/2001 | WO2001090367A1 A novel polypeptide, a human aldehyde/ketone reductase 9.2 and the polynucleotide encoding the polypeptide |
11/29/2001 | WO2001090364A2 Nucleic acid encoding a plant very long chain fatty acid biosynthetic enzyme |
11/29/2001 | WO2001090363A1 Chimeric arterivirus-like particles |
11/29/2001 | WO2001090362A1 Nucleic acids encoding lettuce big-vein virus proteins and utilization thereof |
11/29/2001 | WO2001090361A2 Modulation of inflammation by protease-treated mcp-3 chemokine |
11/29/2001 | WO2001090360A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
11/29/2001 | WO2001090359A2 G-protein coupled receptors |
11/29/2001 | WO2001090358A2 Mammalian receptor proteins; related reagents and methods |
11/29/2001 | WO2001090357A1 Compositions isolated from skin cells and methods for their use |
11/29/2001 | WO2001090356A1 Human pgc-1 promoter |
11/29/2001 | WO2001090355A1 Human sodium channel scn12a and scn8a |
11/29/2001 | WO2001090354A1 Treatment of cancer and neurological diseases |
11/29/2001 | WO2001090353A1 A process for determining the tumoricidal potential of a sample by the use of a nucleic acid which is downregulated in human tumor cells |
11/29/2001 | WO2001090352A1 A novel polypeptide, a centrosome nek-2 binding protein 110.12 and the polynucleotide encoding the polypeptide |
11/29/2001 | WO2001090351A1 A novel polypeptide, a human interleukin binding factor 13.31 and the polynucleotide encoding the polypeptide |
11/29/2001 | WO2001090350A1 A novel polypeptide, a human beta-microtubulin folding co-factor c-9 and the polynucleotide encoding the polypeptide |
11/29/2001 | WO2001090349A1 A novel polypeptide, a human zinc finger protein 12 and the polynucleotide encoding the polypeptide |
11/29/2001 | WO2001090348A1 A novel polypeptide, a human myoglobulin heavy chain 11 and the polynucleotide encoding the polypeptide |
11/29/2001 | WO2001090347A1 Antiviral antisense therapy |
11/29/2001 | WO2001090346A2 Gene recombination and hybrid protein development |
11/29/2001 | WO2001090345A2 Methods and compositions for enhancing the delivery of a nucleic acid to a cell |
11/29/2001 | WO2001090344A1 β-HCG PROMOTER BASED TUMOR-RESTRICTIVE GENE EXPRESSION FOR CANCER GENE THERAPY |
11/29/2001 | WO2001090343A2 Nucleotide sequences encoding ramosa 1 gene and methods of use for same |
11/29/2001 | WO2001090342A2 Genetic engineering of vascular grafts to resist disease |
11/29/2001 | WO2001090341A1 Antisense modulation of pten expression |
11/29/2001 | WO2001090340A2 Assembly of large viral genomes and chromosomes from subclones |
11/29/2001 | WO2001090339A2 Methods and compositions to activate genes in cells |
11/29/2001 | WO2001090338A1 α-ISOMALTOSYLTRANSFERASE, PROCESS FOR PRODUCING THE SAME AND USE THEREOF |
11/29/2001 | WO2001090337A2 Detection of rna |
11/29/2001 | WO2001090334A2 Drug metabolizing enzymes |
11/29/2001 | WO2001090333A2 Recombinant bacterial phytases and uses thereof |
11/29/2001 | WO2001090330A2 AMINOACYL tRNA SYNTHETASES |
11/29/2001 | WO2001090329A2 A novel human acyltransferase family member and uses thereof |
11/29/2001 | WO2001090328A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
11/29/2001 | WO2001090323A2 46638, a putative family member of human lipoxygenase |
11/29/2001 | WO2001090318A2 Regulation of human polyamine oxidase-like enzyme |
11/29/2001 | WO2001090317A2 Beta-galactosidase isolated from a bifidobacterium |
11/29/2001 | WO2001090314A1 Short-root gene, promoter, and uses thereof |
11/29/2001 | WO2001090313A2 METHODS FOR ASSAYING GENE IMPRINTING AND METHYLATED CpG ISLANDS |
11/29/2001 | WO2001090312A1 Ammonia-oxidizing bacteria |
11/29/2001 | WO2001090310A1 PROCESS FOR PRODUCING η-GLUTAMYLCYSTEINE |
11/29/2001 | WO2001090306A2 Compositions and methods for modulating tumor specific expression |
11/29/2001 | WO2001090304A2 Nucleic acids, proteins, and antibodies |
11/29/2001 | WO2001090302A2 Compositions and methods for production of rna viruses and rna virus-based vector particles |
11/29/2001 | WO2001090300A2 Snap back stealth oligonucleotide |